ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity
Go back to ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity| ANI PHARMACEUTICALS (NASDAQ: ANIP) | Delayed: 81.65 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $81.65 | 52 Week High | $70.92 | |||
| Open | $81.65 | 52 Week Low | $26.80 | |||
| Day High | $81.65 | P/E | N/A | |||
| Day Low | $81.65 | EPS | $-0.96 | |||
| Volume | 212 | |||||
